An FDA advisory committee gave the go-ahead for Epidiolex, a marijuana-based drug that treats two rare and severe forms of epilepsy. The FDA is scheduled to vote this June.
An FDA advisory committee gave the go-ahead for Epidiolex, a marijuana-based drug that treats two rare and severe forms of epilepsy. The FDA is scheduled to vote this June.